FENOPRON
Live / Registered — Registered (as of 14 Jul 2026)
What this means for you
Registered since 14 Jul 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 14 Jul 2032: the §8 declaration of use).
Record
- Serial number
- 98699136
- Registration number
- 8346688
- Mark type
- Word mark
- Filed
- 14 Aug 2024
- Published for opposition
- 26 Nov 2024
- Registered
- 14 Jul 2026
- Next maintenance filing
- §8 declaration of use, due by 14 Jul 2032 (grace period to 14 Jan 2033)
- Attorney of record
- Chelsea G. Swanson
Goods and services
- Class 005 — Pharmaceuticals: Analgesic preparations; Anti-inflammatory preparations; Pain relief medication; Pharmaceutical preparations for treating pain and inflammation
Owner
- Galt Pharmaceuticals, LLC, Atlanta, GA, US
- Galt Pharmaceuticals, LLC, Atlanta, GA, US
- Galt Pharmaceuticals, LLC, Atlanta, GA, US
Prosecution history
- 14 Jul 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Jul 2026 — REGISTERED-PRINCIPAL REGISTER
- 21 Jun 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Jun 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Jun 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 11 Feb 2026 — USE AMENDMENT FILED
- 11 Feb 2026 — TEAS STATEMENT OF USE RECEIVED
- 11 Feb 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 11 Feb 2026 — NOTICE OF REVIVAL - E-MAILED
- 11 Feb 2026 — PETITION TO REVIVE-GRANTED
- 11 Feb 2026 — TEAS PETITION TO REVIVE RECEIVED
- 09 Feb 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 09 Feb 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 20 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Jun 2025 — SOU EXTENSION 1 GRANTED